DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM.
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.
Clin Cancer Res 2005;
11: 8680-8685
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.